(18.117.158.141)
Users online: 14238     
Ijournet
Email id
 

Research Journal of Pharmacy and Technology
Year : 2023, Volume : 16, Issue : 1
First page : ( 179) Last page : ( 183)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.52711/0974-360X.2023.00033

Assessment of adverse events following immunization of COVID - 19 vaccination in health care workers (HCWs) of Shaheed Hasan Khan Mewati Govt. Medical College Nalhar, Nuh, Haryana, India

Sharma Kapil1, Ranga Parven2,*, Singh Maha3, Kumar Rajeev4, Khan Haroon5, Tanwar Vikram6

1Assistant Professor, Tuberculosis and Respiratory Diseases, SHKMGMC

2Senior resident Deptt., Dentistry, SHKMGMC

3Professor Deptt., Pediatrics, SHKMGMC

4Associate Professor, Community Medicine, SHKMGMC

5Assistant Professor Deptt., of Medicine, SHKMGMC

6Professor Deptt., of Forensic Medicine, SHKMGMC

*Corresponding Author E-mail: dr.parveenranga@gmail.com

Online Published on 10 October, 2023.

Abstract

Background

We assess the profile of adverse events following immunization of COVID - 19 vaccination of COVISHIELD in health care workers (HCWs) in Shaheed Hasan Khan Mewati Govt. Medical college Nalhar, Nuh, Haryana, India.

Methods

The Cross sectional and prospective observational study was conducted with a period of 3 months or till the desired sample size recruited in the study with follow up period of 15 days for all those subjects who were vaccinated for covid-19 in SHKM, GMC Hospital to look for AEFI with sample size more than 300. Active surveillance was done on days 3, 6 and 9 after days of vaccination for AEFI). Any AEFI noted will be managed as per the standard guidelines.

Results

We present the results of an interim analysis of 400 patients out of total 550 participants with 244(61.00%) male and 156 (39.00%) female participants respectively. AEFIs following first dose were reported in 400 participants and 269 participants after second dose. Fever was the major AEFI with 150(37.50%) after first dose and 78(28.99%) after second dose respectively. In the study age wise AEFIs percentage of participants were also calculated. In the present study different systemic diseases percentage also calculated.

Conclusion

The AEFIs associated with the COVISHIELD (ChAdOx1 nCoV-19), the COVID-19 vaccine injected in hospital health care workers is found to be safe for use in except for a few minor reactions.

Top

Keywords

COVISHIELD, COVID-19, Vaccination, Adverse Events Following Immunization, AEFI.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
750,876,371 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.